TABLE 1.
CI user | Gender | Age | Ear | Etiology | Duration of CI use | Measurement electrodesa |
---|---|---|---|---|---|---|
U01 | F | 57 | R | Genetic | 5 years | S11-R09; S20-R22 |
U02 | F | 55 | R | Genetic | 3 years | S11-R13; S20-R22 |
U03 | F | 27 | R | Meningitis | 9 months | S11-R13; S20-R22 |
U04 | F | 50 | R | Genetic | 6 years | S11-R13; S20-R22 |
U05 | F | 48 | L | Unknown | 2 years | S11-R13; S20-R22 |
U06 | F | 36 | L | Congenital progressive | 1 year | S11-R13; S20-R22 |
U07 | F | 77 | R | Unknown | 7 years | S20-R22 |
U08 | F | 56 | L | Pendred syndrome | 8 years | S04-R06 |
U09 | M | 61 | L | Trauma | 5 years | S15-R17 |
CI cochlear implant, F female, M male, L left, R right
aS## indicates the stimulation electrode, and R## indicates the recording electrode